Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 1211-1218 , November 2009

Does vascular surgery cost too much?

  • G. Patrick Clagett, MD

      Affiliations

    • Corresponding Author InformationReprint requests: G. Patrick Clagett, MD, Division of Vascular and Endovascular Surgery, University of Texas Southwestern Medical Center, 5909 Harry Hines Boulevard, Dallas, TX 75390-9157

References 

  1. Johnston KW. The Society for Vascular Surgery – State of the Society, 2008. J Vasc Surg. 2008;48:1613–1619
  2. US National Debt Clock. http://www.usdebtclock.orgAccessed March 17, 2009.
  3. Keehan S, Sisko A, Tuffer C, Smith S, Cowan C, Poisal J, et al. Health spending projections through 2017: the baby-boom generation is coming to Medicare. Health Aff. 2008;27:w145–w155
  4. Hartman M, Catlin A, Lasman D, Cylus J, Heffler S. US health spending by age, selected years through 2004. Health Aff. 2008;27:w1–w12
  5. Health care spending – UC atlas of global inequality. http://ucatlas.ucsc.edu/spend.phpAccessed on February 10, 2009.
  6. In:  Wennberg J,  Fisher E,  Goodman D,  Skinner J editor. Tracking the care of patients with severe chronic illness: The Dartmouth atlas of health care 2008. Lebanon, (NH): The Dartmouth Institute for Health Policy and Clinical Practice; 2008;
  7. Sirovich B, Gallagher P, Wennberg D, Fisher E. Discretionary decision making by primary care physicians and the cost of US health care. Health Aff. 2008;27:813–823
  8. Fisher E, Bynum J, Skinner J. Slowing the growth of health care costs – lessons from regional variation. N Engl J Med. 2009;360:849–852
  9. Dartmouth – CMS – FDA collaborative. Trends and regional variations in abdominal aortic aneurysm repair. http://www.dartmouthatlas.org/atlases/AAA_report_2006.pdfFebruary 1, 2006;Accessed March 2009.
  10. Gawande A. Annals of medicine - The cost conundrum: What a Texas town can teach us about health care (The New Yorker). http://www.newyorker.com/reporting/2009/06/01/090601fa_fact_gawandeJune 1, 2009;Accessed June 1, 2009.
  11. CBO paper (Research on the comparative effectiveness of medical treatments: Issues and options for an expanded federal role). http://www.cbo.gov/ftpdocs/88xx/doc8891/12-18-ComparativeEffectiveness.pdfDecember 2007;Accessed March 2009.
  12. Gibbons R, Gardner T, Anderson J, Goldstein L, Meltzer N, Weintraub W, et al. The American Heart Association's principles for comparative effectiveness research – policy statement from the American Heart Association. Circulation. 2009;119:2955–2962
  13. Slutsky J, Atkins D, Chang S, Sharp B. Comparing medical interventions: AHRQ and the effective health care program. J Clin Epidemiol. June 2008;Sept 30;[Epublication ahead of print].
  14. Steinbrook R. Saying no isn't NICE – the travails of Britain's National Institute for Health and Clinical Excellence. N Engl J Med. 2008;359:19
  15. NHS. NICE technology appraisal guidance 167 (Endovascular stent grafts for the treatment of abdominal aortic aneurysms). http://www.nice.org.uk/nicemedia/pdf/TA167Guidance.pdfFebruary 2009;Accessed February 2009.
  16. DeMaria A. Comparative effectiveness research. J Am Coll Cardiol. 2009;53:973–975
  17. Garber A, Tunis Sean. Does comparative-effectiveness research threaten personalized medicine?. N Engl J Med. 2009;360:1925–1927
  18. Sidawy A, Zwolak R, White R, Simami F, Schermerhorn M, Sicard G. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg. 2009;49:71–79
  19. Ad Hoc Task Force. Comparative effectiveness and vascular surgery. J Vasc Surg. 2009;(in press).
  20. Spronk S, Bosch J, den Hoed P, Veen H, Pattynama P, Hunink M. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg. 2008;48:1472–1480
  21. Greenhalgh R, Belch J, Brown L, Gaines P, Gao L, Reise J, et al. The MIMIC Trial Participants (The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice, and best medical therapy: results from two randomized trials for stenotic femoropopliteal and aortoiliac arterial disease). Eur J Vasc Endovasc Surg. 2008;36:680–688
  22. Spronk S, Bosch J, den Hoed P, Veen H, Pattynama P, Hunink M. Intermittent claudication: clinical effectiveness of endovascular revascularization vs supervised hospital-based exercise training randomized controlled trial. Radiology. 2009;250:586–595
  23. Pear R. US to compare medical treatments (New York Times). http://www.nytimes.com/2009/02/16/health/policy/16health.html?hpAccessed February 16, 2009.
  24. Clagett GP. EVAR, TEVAR, FEVAR, too far?. Perspectives Vasc Surg Endovasc Ther. 2008;20:115–119
  25. Hertzer N. Presidential address: outcome assessment in vascular surgery – results mean everything. J Vasc Surg. 1995;21:6–15

 Competition of interest: none.

 Presented at Annual Meeting of the Society for Vascular Surgery, Denver, Colo, June 10-14, 2009.

PII: S0741-5214(09)01451-7

doi: 10.1016/j.jvs.2009.06.063

Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 1211-1218 , November 2009

Article Tools

* Image Usage & Resolution